Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results

Arizona Tribune - Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results

Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results

LOS GATOS, CA / ACCESS Newswire / August 5, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the second quarter 2025 ended June 30, 2025 after market close on Wednesday, August 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.

Text size:

Date:	Wednesday, August 13, 2025
Time:	4:30 p.m. Eastern time
Dial-in:	1-877-407-0792
International Dial-in:	1-201-689-8263
Webcast:	TNON Conference Call

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

An audio playback of the call will be available through August 27, 2025, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13754961.

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit www.tenonmed.com.

The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAIL^TM is also a trademark of Tenon Medical, Inc.

Investor Contact
Shannon Devine
MZ North America
203-741-8811
[email protected]

SOURCE: Tenon Medical, Inc.

View the original press release on ACCESS Newswire

Th.Gonzalez--AT

CMSD	-0.09%	21.16	$
CMSC	0.05%	21.3	$
BCE	0.55%	23.59	$
RYCEF	-1.49%	20.2	$
RBGPF	0%	70.69	$
JRI	-1.4%	12.18	$
BCC	-0.95%	78.01	$
RIO	-0.78%	102.5	$
AZN	-0.35%	162.13	$
BP	1.68%	42.87	$
RELX	-0.3%	36.43	$
NGG	-0.24%	79.16	$
BTI	-1.01%	55.57	$
GSK	-1.13%	50.25	$
VOD	0%	16.04	$

Arizona Tribune - Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results

Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results

Featured

Jury begins deliberations in Tupac Shakur murder trial

ChatGPT becomes first AI chatbot to face tougher EU rules

Malaysia's Sarawak eyes cloud seeding as haze worsens

Transitional Fashion Essentials for Autumn: Key Pieces from M&S and Joe Browns